Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Otsuka and Lundbeck file Abilify follow-up in the US

Otsuka and Lundbeck file Abilify follow-up in the US Otsuka and Lundbeck have filed for approval of brexpiprazole - their follow-up to blockbuster antipsychotic Abilify - in the US. ... year. A long-acting follow-up called Abilify Maintena reached the market last year, which helped defend the franchise

Lundbeck's desmoteplase flunks phase III stroke trial

Lundbeck's desmoteplase flunks phase III stroke trial vortioxetine), once-monthly schizophrenia drug Abilify Maintena (aripiprazole) and alcohol dependence therapy Selincro (nalmefene).

Back to the future

Back to the future Only Seretide/Advair ($8.4bn), Abilify ($8bn) and Crestor ($6.9bn) prevented a biologic clean sweep of the bestsellers. .

Lundbeck agrees $658m deal to buy Chelsea Therapeutics

Lundbeck agrees $658m deal to buy Chelsea Therapeutics such as antidepressant Brintellix (vortioxetine) and Abilify Maintena (aripiprazole) to build sales momentum.

Double win for J&J's schizophrenia franchise

Double win for J&J's schizophrenia franchise leg-up in the market over competitors such as Lilly's Zypadhera (olanzapine) and Lundbeck's Abilify Maintena (aripiprazole), which has just been introduced in Europe.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics